We are live on ! Find out more
LCM

Laurion Capital Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 75.73%
This Fund
S&P 500
This Quarter Est. Return
+2.87%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$21.4B
AUM Growth
+$4.44B
Cap. Flow
+$3.37B
Cap. Flow %
15.75%
Top 10 Hldgs %
23.93%
Holding
573
New
101
Increased
135
Reduced
75
Closed
168

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$235M
2
AMZN icon
Amazon
AMZN
+$216M
3
ATVI
Activision Blizzard
ATVI
+$191M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$93.2M
5
TSLA icon
Tesla
TSLA
+$76.8M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$114M
2
TGT icon
Target
TGT
+$112M
3
TMUS icon
T-Mobile US
TMUS
+$104M
4
C icon
Citigroup
C
+$99.3M
5
TWTR
Twitter, Inc.
TWTR
+$92.5M

Sector Composition

Rank Sector Weight
1 Technology 3.92%
2 Healthcare 3.45%
3 Consumer Discretionary 3.2%
4 Communication Services 2.88%
5 Utilities 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OMGA
301
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$2.47M 0.01%
432,700
– –
BCAB icon
302
BioAtla
BCAB
$5.76M
$2.41M 0.01%
5,852
– –
ETNB
303
DELISTED
89bio
ETNB
$2.38M 0.01%
187,100
– –
OYST
304
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$2.35M 0.01%
210,200
– –
CTMX icon
305
CytomX Therapeutics
CTMX
$750M
$2.03M 0.01%
1,270,900
– –
ADI icon
306
Analog Devices
ADI
$187B
$2.03M 0.01%
+12,350
New +$1.93M
NOW icon
307
ServiceNow
NOW
$132B
$2.02M 0.01%
+25,955
New +$2.03M
ILMN icon
308
PUT
Illumina
ILMN
$29B
$2M 0.01%
+10,177
New +$2.11M
LENZ
309
LENZ Therapeutics
LENZ
$168M
$1.9M 0.01%
81,943
– –
BKNG icon
310
CALL
Booking.com
BKNG
$160B
$1.81M 0.01%
+22,500
New +$1.71M
LPLA icon
311
LPL Financial
LPLA
$29.3B
$1.73M 0.01%
+8,000
New +$1.87M
VIGL
312
DELISTED
Vigil Neuroscience
VIGL
$1.63M 0.01%
130,200
– –
CMPS
313
Compass Pathways
CMPS
$1.78B
$1.52M 0.01%
189,407
– –
ILMN icon
314
Illumina
ILMN
$29B
$1.52M 0.01%
+7,731
New +$1.6M
IMA
315
ImageneBio Inc
IMA
$64.9M
$1.41M 0.01%
44,083
– –
EDIT icon
316
Editas Medicine
EDIT
$432M
$1.24M 0.01%
140,000
-659
-0.5% -$7.23K
OLMA icon
317
Olema Pharmaceuticals
OLMA
$1.04B
$1.21M 0.01%
495,300
– –
SCPH
318
DELISTED
scPharmaceuticals
SCPH
$1.18M 0.01%
+165,000
New +$1.01M
ATOS icon
319
Atossa Therapeutics
ATOS
$23.6M
$1.18M 0.01%
148,387
– –
STTK icon
320
Shattuck Labs
STTK
$682M
$1.16M 0.01%
506,000
– –
PCG icon
321
PG&E
PCG
$37.5B
$1.14M 0.01%
70,000
-1,730,404
-96% -$26.2M
IHS icon
322
IHS Holding
IHS
$2.79B
$1.13M 0.01%
183,173
– –
PRME icon
323
Prime Medicine
PRME
$571M
$1.11M 0.01%
+60,000
New +$1.08M
ISEE
324
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$1.11M 0.01%
51,900
-971
-2% -$20.7K
ECVT icon
325
Ecovyst
ECVT
$1.1B
$1.1M 0.01%
+123,600
New +$1.14M
11 12
13
14 15

Similar funds

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
NSAM
North Star Asset Management Neenah, Wisconsin $2.31B AUM 10.09% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return
OCM
Oribel Capital Management New York $2.27B AUM 60.32% 1-Year Est. Return

Laurion Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Laurion Capital Management held 573 positions worth $21.4B, up 26% from $16.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Laurion Capital Management deployed $3.37B of net new capital in Q4 2022, opening 101 new positions and adding to 135 existing holdings. Its largest new stake was Tesla: 405,456 shares worth $49.9M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Target, an estimated $112M trimmed.

  • Laurion Capital Management's largest Q4 2022 buy was Tesla: 405,456 shares worth $49.9M.
  • Laurion Capital Management added most to Apple in Q4 2022, an estimated $235M increase.
  • Laurion Capital Management's biggest Q4 2022 reduction was Target, cutting an estimated $112M.
  • Laurion Capital Management fully exited JPMorgan Chase in Q4 2022, selling an estimated $114M.
  • Laurion Capital Management's ten largest holdings make up 24% of its $21.4B portfolio in Q4 2022.
  • Laurion Capital Management opened 101 new positions and closed 168 in Q4 2022.
  • Laurion Capital Management's portfolio value rose 26% quarter-over-quarter to $21.4B.

Based on Laurion Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.